Balster R L
Eur J Pharmacol. 1986 Aug 15;127(3):283-6. doi: 10.1016/0014-2999(86)90377-8.
The functional significance of the reported affinity of (+)-3-PPP and (+)-N-allylnormetazocine (NANM) for the same binding site in rat brain membranes was assessed by studying (+)-3-PPP as a agonist and antagonist of (+)-NANM in rats trained to discriminate 5.0 mg/kg (+)-NANM from saline. Over a wide dose range, (+)-3-PPP was able to block the discriminative stimulus effects of (+)-NANM, with complete antagonism at 1.0 mg/kg i.p. Since (+)-NANM is a prototype sigma-opioid agonist, (+)-3-PPP is a good candidate for being a competitive sigma antagonist.
通过在经过训练可区分5.0毫克/千克(+)-烯丙基去甲佐辛(NANM)和生理盐水的大鼠中,研究(+)-3-苯基-1-丙基哌嗪(+)-3-PPP)作为(+)-NANM的激动剂和拮抗剂,评估了所报道的(+)-3-PPP和(+)-烯丙基去甲佐辛(NANM)对大鼠脑膜中同一结合位点的亲和力的功能意义。在很宽的剂量范围内,(+)-3-PPP能够阻断(+)-NANM的辨别刺激效应,腹腔注射1.0毫克/千克时完全拮抗。由于(+)-NANM是一种典型的σ-阿片受体激动剂,(+)-3-PPP是一种很好的竞争性σ拮抗剂候选物。